Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aura Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aura Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Person Julie | Chief People Officer | 107,611 | Sep 1, 2026 | 1 |
| Kratz Erica | Chief Reg. & Quality Officer | 100,885 | Sep 1, 2026 | 1 |
| Hopkins Janet Jill | Chief Medical Officer | 380,190 | Sep 1, 2026 | 4 |
| Elazzouzi Amy | SVP, Finance & PAO | 143,600 | Sep 1, 2026 | 5 |
| Abu-Absi Susan | Chief Operating Officer | 134,513 | Sep 1, 2026 | 1 |
| Bender Jeremy | Director | 30,000 | Jul 8, 2026 | 1 |
| Kilroy Conor | See Remarks | 232,693 | Jul 1, 2026 | 4 |
| Gibney Anthony S | See Remarks | 265,354 | Jun 16, 2026 | 2 |
| Srivastava Sapna | Director | 38,500 | Jun 15, 2026 | 1 |
| Mattessich Antony C. | Director | 38,500 | Jun 15, 2026 | 1 |
| Johnson David Michael | Director | 194,167 | Jun 15, 2026 | 1 |
| Bitetti Teresa Marie | Director | 36,000 | Jun 15, 2026 | 1 |
| Holles Natalie C. | See Remarks | 1,153,962 | May 19, 2026 | 1 |
| Matrix Capital Management Company, LP | 10% Owner | 0Indirect | May 11, 2026 | 1 |
| Goel David E. | 10% Owner | 0Indirect | May 11, 2026 | 1 |
| Plavsic Mark | Chief Technology Officer | 243,736 | Mar 3, 2026 | 3 |
| de los Pinos Elisabet | See Remarks | 575,815 | Mar 3, 2026 | 4 |
| Feder Julie B | Chief Financial Officer | 134,276 | Oct 21, 2024 | 0 |
| Parekh Rajesh B | Director | – | Jun 9, 2023 | 0 |
| De Rosch Mark | Chief Operating Officer | 58,635 | Jan 23, 2023 | 0 |
| Rich Cadmus | See Remarks | 58,703 | Jan 23, 2023 | 0 |
| Medicxi Growth I LP | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Growth Co-Invest I LP | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Ventures Management (Jersey) Ltd | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Medicxi Growth I GP Ltd | 10% Owner | 70,540Indirect | Nov 4, 2021 | 0 |
| Primiano Christopher Brett | Chief Business Officer | 8,750 | Oct 29, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | de los Pinos ElisabetSee Remarks | SSale | −5.71K | $12.46 | −$71.1K | −7.7%68.7K after | |
| Nov 2, 2022 (view filing) | Oct 31 | 2 days | De Rosch MarkChief Operating Officer | SSale | −1.11K | $12.46 | −$13.9K | −6.4%16.4K after | |
| Jun 14, 2022 (view filing) | Jun 10-13 | 4 days | Johnson David MichaelDirector | PPurchase | +20.0K | $14.31 | +$286.1K | New position10.0K after | 4 lots |
| Jun 14, 2022 (view filing) | Jun 10-13 | 4 days | Johnson David MichaelDirector | PPurchase | +30.0K | $14.34 | +$430.2K | New position30.0K after | 2 lots |
| Nov 4, 2021 (view filing)5:00 PM ET | Nov 2 | 2 days | Medicxi Growth I LP and 3 others10% Owner | PPurchase | +710.0K | $14.00 | +$9.94M | New position70.5K after | 2 lots |
| Nov 4, 2021 (view filing)4:44 PM ET | Nov 2 | 2 days | Matrix Capital Management Company, LP and 1 other10% Owner | PPurchase | +1.78M | $14.00 | +$25.0M | +76.7%4.11M after |